

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.63816618 |
| 2 | viral transcription (GO:0019083) | 6.32632935 |
| 3 | translational termination (GO:0006415) | 6.10318861 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 5.89248993 |
| 5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.26338451 |
| 6 | translational elongation (GO:0006414) | 5.20648607 |
| 7 | cotranslational protein targeting to membrane (GO:0006613) | 5.15992164 |
| 8 | protein targeting to ER (GO:0045047) | 5.15001254 |
| 9 | protein neddylation (GO:0045116) | 4.95370865 |
| 10 | maturation of SSU-rRNA (GO:0030490) | 4.93205472 |
| 11 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.89400200 |
| 12 | protein localization to endoplasmic reticulum (GO:0070972) | 4.83150278 |
| 13 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.70826784 |
| 14 | viral life cycle (GO:0019058) | 4.69731185 |
| 15 | cellular protein complex disassembly (GO:0043624) | 4.61619303 |
| 16 | translational initiation (GO:0006413) | 4.60723765 |
| 17 | ribosomal large subunit biogenesis (GO:0042273) | 4.44507681 |
| 18 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.42479500 |
| 19 | ATP synthesis coupled proton transport (GO:0015986) | 4.42479500 |
| 20 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.10768650 |
| 21 | respiratory electron transport chain (GO:0022904) | 4.03363110 |
| 22 | protein complex disassembly (GO:0043241) | 3.97575384 |
| 23 | electron transport chain (GO:0022900) | 3.92313181 |
| 24 | piRNA metabolic process (GO:0034587) | 3.86603739 |
| 25 | formation of translation preinitiation complex (GO:0001731) | 3.86377548 |
| 26 | base-excision repair, AP site formation (GO:0006285) | 3.83860363 |
| 27 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.71488049 |
| 28 | macromolecular complex disassembly (GO:0032984) | 3.69462667 |
| 29 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.63640564 |
| 30 | protein targeting to mitochondrion (GO:0006626) | 3.61537805 |
| 31 | aerobic respiration (GO:0009060) | 3.55521205 |
| 32 | translation (GO:0006412) | 3.49509480 |
| 33 | protein localization to mitochondrion (GO:0070585) | 3.43108814 |
| 34 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.42791690 |
| 35 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.39343566 |
| 36 | protein targeting to membrane (GO:0006612) | 3.38937056 |
| 37 | protein maturation by protein folding (GO:0022417) | 3.34427801 |
| 38 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.32624121 |
| 39 | ribonucleoprotein complex disassembly (GO:0032988) | 3.24728385 |
| 40 | mRNA catabolic process (GO:0006402) | 3.24093511 |
| 41 | establishment of protein localization to mitochondrion (GO:0072655) | 3.23391175 |
| 42 | protein complex biogenesis (GO:0070271) | 3.20043835 |
| 43 | chaperone-mediated protein transport (GO:0072321) | 3.19223181 |
| 44 | regulation of meiosis I (GO:0060631) | 3.18776476 |
| 45 | deoxyribonucleotide catabolic process (GO:0009264) | 3.17988261 |
| 46 | cullin deneddylation (GO:0010388) | 3.17403403 |
| 47 | deoxyribose phosphate catabolic process (GO:0046386) | 3.15613697 |
| 48 | regulation of mitochondrial translation (GO:0070129) | 3.14909139 |
| 49 | respiratory chain complex IV assembly (GO:0008535) | 3.12841994 |
| 50 | inner mitochondrial membrane organization (GO:0007007) | 3.08920594 |
| 51 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.08163650 |
| 52 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.07148079 |
| 53 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.07148079 |
| 54 | NADH dehydrogenase complex assembly (GO:0010257) | 3.07148079 |
| 55 | RNA catabolic process (GO:0006401) | 3.04081696 |
| 56 | purine-containing compound salvage (GO:0043101) | 3.01179443 |
| 57 | positive regulation of ligase activity (GO:0051351) | 3.00818446 |
| 58 | organelle disassembly (GO:1903008) | 2.97633581 |
| 59 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.96531025 |
| 60 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.91163001 |
| 61 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.87723654 |
| 62 | cytochrome complex assembly (GO:0017004) | 2.85201943 |
| 63 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.83340590 |
| 64 | rRNA modification (GO:0000154) | 2.82994502 |
| 65 | DNA methylation involved in gamete generation (GO:0043046) | 2.79848118 |
| 66 | mitochondrial transport (GO:0006839) | 2.78981922 |
| 67 | interferon-gamma secretion (GO:0072643) | 2.76210058 |
| 68 | DNA strand elongation (GO:0022616) | 2.72767413 |
| 69 | xenobiotic catabolic process (GO:0042178) | 2.72256847 |
| 70 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.72007056 |
| 71 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.69782117 |
| 72 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.69782117 |
| 73 | protein deneddylation (GO:0000338) | 2.69100236 |
| 74 | cellular respiration (GO:0045333) | 2.68414150 |
| 75 | aldehyde catabolic process (GO:0046185) | 2.68044782 |
| 76 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.67081182 |
| 77 | viral protein processing (GO:0019082) | 2.66836300 |
| 78 | rRNA processing (GO:0006364) | 2.61929492 |
| 79 | DNA unwinding involved in DNA replication (GO:0006268) | 2.61732173 |
| 80 | regulation of activation of Janus kinase activity (GO:0010533) | 2.58158640 |
| 81 | DNA deamination (GO:0045006) | 2.54237637 |
| 82 | cellular component biogenesis (GO:0044085) | 2.53390237 |
| 83 | rRNA metabolic process (GO:0016072) | 2.49423315 |
| 84 | telomere maintenance via recombination (GO:0000722) | 2.47736008 |
| 85 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.46485254 |
| 86 | mitotic recombination (GO:0006312) | 2.40759750 |
| 87 | positive regulation of immune response to tumor cell (GO:0002839) | 2.39062172 |
| 88 | regulation of immune response to tumor cell (GO:0002837) | 2.39062172 |
| 89 | regulation of response to tumor cell (GO:0002834) | 2.39062172 |
| 90 | positive regulation of response to tumor cell (GO:0002836) | 2.39062172 |
| 91 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.37857391 |
| 92 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.34557277 |
| 93 | CENP-A containing nucleosome assembly (GO:0034080) | 2.33253599 |
| 94 | nucleobase biosynthetic process (GO:0046112) | 2.32842662 |
| 95 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.32779065 |
| 96 | purine nucleobase biosynthetic process (GO:0009113) | 2.32550250 |
| 97 | response to interferon-beta (GO:0035456) | 2.30668510 |
| 98 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.30622234 |
| 99 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.30622234 |
| 100 | folic acid metabolic process (GO:0046655) | 2.30035224 |
| 101 | nucleoside salvage (GO:0043174) | 2.29971610 |
| 102 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.28791853 |
| 103 | regulation of RIG-I signaling pathway (GO:0039535) | 2.27975741 |
| 104 | ribosome assembly (GO:0042255) | 2.26859012 |
| 105 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.24240104 |
| 106 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.24240104 |
| 107 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.23861078 |
| 108 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.23563944 |
| 109 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.22320826 |
| 110 | glycine metabolic process (GO:0006544) | 2.21931201 |
| 111 | DNA replication initiation (GO:0006270) | 2.20815290 |
| 112 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.19904294 |
| 113 | DNA replication checkpoint (GO:0000076) | 2.19404463 |
| 114 | telomere maintenance via telomere lengthening (GO:0010833) | 2.19362794 |
| 115 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.19188925 |
| 116 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.19188925 |
| 117 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.19188925 |
| 118 | ncRNA 3-end processing (GO:0043628) | 2.18545368 |
| 119 | primary alcohol catabolic process (GO:0034310) | 2.17691514 |
| 120 | oxidative phosphorylation (GO:0006119) | 2.17433813 |
| 121 | establishment of protein localization to membrane (GO:0090150) | 2.16366501 |
| 122 | chromatin remodeling at centromere (GO:0031055) | 2.15337628 |
| 123 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.14285884 |
| 124 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.14285884 |
| 125 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.13929513 |
| 126 | natural killer cell mediated immunity (GO:0002228) | 2.13929513 |
| 127 | ribosome biogenesis (GO:0042254) | 2.13781771 |
| 128 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.12887483 |
| 129 | cellular response to interferon-beta (GO:0035458) | 2.11349642 |
| 130 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.10510461 |
| 131 | DNA damage response, detection of DNA damage (GO:0042769) | 2.07961396 |
| 132 | establishment of protein localization to organelle (GO:0072594) | 2.07062075 |
| 133 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.06952319 |
| 134 | termination of RNA polymerase III transcription (GO:0006386) | 2.05416130 |
| 135 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.05416130 |
| 136 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.04910007 |
| 137 | tetrahydrofolate metabolic process (GO:0046653) | 2.03476256 |
| 138 | protein targeting (GO:0006605) | 2.03071934 |
| 139 | positive regulation of interferon-alpha production (GO:0032727) | 2.03035921 |
| 140 | proteasome assembly (GO:0043248) | 2.02347889 |
| 141 | pseudouridine synthesis (GO:0001522) | 2.01369053 |
| 142 | negative regulation of ligase activity (GO:0051352) | 2.00423329 |
| 143 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.00423329 |
| 144 | serine family amino acid biosynthetic process (GO:0009070) | 1.99988811 |
| 145 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 1.99549043 |
| 146 | regulation of cellular amino acid metabolic process (GO:0006521) | 1.99081732 |
| 147 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 1.97982608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.19229383 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.59173491 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.22616439 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.93899548 |
| 5 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.85939474 |
| 6 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.77229726 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.68942461 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.48819105 |
| 9 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.46770103 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.42535026 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.41001803 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.32487659 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.28345846 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.28180812 |
| 15 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.21706733 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.20290817 |
| 17 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.17873246 |
| 18 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.15968570 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.15255516 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.10578421 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.04517282 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.01630827 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.99072507 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.98890493 |
| 25 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.97717547 |
| 26 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.86210513 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.84653828 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.84434662 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.83667490 |
| 30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.79651854 |
| 31 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.79103637 |
| 32 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.78737281 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72763951 |
| 34 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.71675439 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.71317114 |
| 36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68041802 |
| 37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67055068 |
| 38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.65834928 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.63960980 |
| 40 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.61919446 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60804511 |
| 42 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.59142370 |
| 43 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.55565897 |
| 44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.53264412 |
| 45 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.51421894 |
| 46 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.47457962 |
| 47 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.47247830 |
| 48 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.45055975 |
| 49 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.43456182 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.41920733 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.39840226 |
| 52 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.39255965 |
| 53 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38557845 |
| 54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.38074246 |
| 55 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.36786571 |
| 56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35777887 |
| 57 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.35270653 |
| 58 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.33566333 |
| 59 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33445944 |
| 60 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32425050 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.31766156 |
| 62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.31127743 |
| 63 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.31098564 |
| 64 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.28172641 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27369820 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25397131 |
| 67 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.25391991 |
| 68 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.25380631 |
| 69 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23776049 |
| 70 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23377280 |
| 71 | MYC_22102868_ChIP-Seq_BL_Human | 1.22482934 |
| 72 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.22031388 |
| 73 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21668314 |
| 74 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21492437 |
| 75 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.20773354 |
| 76 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.19976837 |
| 77 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19958831 |
| 78 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15542982 |
| 79 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.14667409 |
| 80 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.14467074 |
| 81 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11370633 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10771152 |
| 83 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.10113222 |
| 84 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.08991694 |
| 85 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.08333894 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05450624 |
| 87 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.05345372 |
| 88 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.05291770 |
| 89 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03345806 |
| 90 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03289568 |
| 91 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.03208306 |
| 92 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.03077445 |
| 93 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.02618504 |
| 94 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01808163 |
| 95 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.01382747 |
| 96 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00624609 |
| 97 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.99157041 |
| 98 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98098820 |
| 99 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.97263252 |
| 100 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.97110030 |
| 101 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97101455 |
| 102 | MYB_26560356_Chip-Seq_TH2_Human | 0.96684588 |
| 103 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94649679 |
| 104 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.94151060 |
| 105 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93657781 |
| 106 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93575822 |
| 107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92899552 |
| 108 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.92419383 |
| 109 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.92173489 |
| 110 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.92165819 |
| 111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.90109683 |
| 112 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.89870117 |
| 113 | MAF_26560356_Chip-Seq_TH1_Human | 0.89684945 |
| 114 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.89250297 |
| 115 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.88716250 |
| 116 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.88272228 |
| 117 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.88169138 |
| 118 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87354544 |
| 119 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.86310643 |
| 120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86273775 |
| 121 | VDR_22108803_ChIP-Seq_LS180_Human | 0.83422619 |
| 122 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.76221535 |
| 123 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.73671960 |
| 124 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.72697218 |
| 125 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.72538691 |
| 126 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.67432973 |
| 127 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.66068114 |
| 128 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.64907728 |
| 129 | FUS_26573619_Chip-Seq_HEK293_Human | 0.62985483 |
| 130 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.62133310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 3.62590222 |
| 2 | MP0000372_irregular_coat_pigmentation | 3.33904732 |
| 3 | MP0005084_abnormal_gallbladder_morpholo | 2.77494370 |
| 4 | MP0003123_paternal_imprinting | 2.60910678 |
| 5 | MP0003693_abnormal_embryo_hatching | 2.54949686 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.54096795 |
| 7 | MP0006035_abnormal_mitochondrial_morpho | 2.46387975 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.45328732 |
| 9 | MP0005464_abnormal_platelet_physiology | 2.44530719 |
| 10 | MP0009785_altered_susceptibility_to | 2.43111758 |
| 11 | MP0004957_abnormal_blastocyst_morpholog | 2.36470418 |
| 12 | MP0002102_abnormal_ear_morphology | 2.33849363 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.32322132 |
| 14 | MP0000685_abnormal_immune_system | 2.22631445 |
| 15 | MP0002163_abnormal_gland_morphology | 2.05864682 |
| 16 | MP0009379_abnormal_foot_pigmentation | 2.03726810 |
| 17 | MP0003186_abnormal_redox_activity | 2.01629154 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.00237986 |
| 19 | MP0005360_urolithiasis | 1.95369243 |
| 20 | MP0010094_abnormal_chromosome_stability | 1.94069554 |
| 21 | MP0003787_abnormal_imprinting | 1.83966108 |
| 22 | MP0003077_abnormal_cell_cycle | 1.75603886 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.75151574 |
| 24 | MP0005025_abnormal_response_to | 1.72469929 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 1.71562912 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.70534840 |
| 27 | MP0003786_premature_aging | 1.68642452 |
| 28 | MP0002139_abnormal_hepatobiliary_system | 1.65634894 |
| 29 | MP0002277_abnormal_respiratory_mucosa | 1.60459712 |
| 30 | MP0005671_abnormal_response_to | 1.58096545 |
| 31 | MP0001800_abnormal_humoral_immune | 1.56736113 |
| 32 | MP0000490_abnormal_crypts_of | 1.55827926 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.55745710 |
| 34 | MP0001853_heart_inflammation | 1.54201049 |
| 35 | MP0008007_abnormal_cellular_replicative | 1.52839716 |
| 36 | MP0002254_reproductive_system_inflammat | 1.51100798 |
| 37 | MP0002006_tumorigenesis | 1.49842572 |
| 38 | MP0004142_abnormal_muscle_tone | 1.48118076 |
| 39 | MP0005387_immune_system_phenotype | 1.47189192 |
| 40 | MP0001790_abnormal_immune_system | 1.47189192 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.46673331 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.46244747 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.46068173 |
| 44 | MP0004145_abnormal_muscle_electrophysio | 1.45383716 |
| 45 | MP0002132_abnormal_respiratory_system | 1.43831676 |
| 46 | MP0003121_genomic_imprinting | 1.41752606 |
| 47 | MP0003436_decreased_susceptibility_to | 1.41450671 |
| 48 | MP0002723_abnormal_immune_serum | 1.39391508 |
| 49 | MP0000015_abnormal_ear_pigmentation | 1.38600863 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.38417232 |
| 51 | MP0001986_abnormal_taste_sensitivity | 1.36665440 |
| 52 | MP0008057_abnormal_DNA_replication | 1.34943387 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 1.34601432 |
| 54 | MP0003111_abnormal_nucleus_morphology | 1.34398312 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.33353158 |
| 56 | MP0010386_abnormal_urinary_bladder | 1.32114383 |
| 57 | MP0001819_abnormal_immune_cell | 1.31977979 |
| 58 | MP0002420_abnormal_adaptive_immunity | 1.31830993 |
| 59 | MP0000749_muscle_degeneration | 1.31381774 |
| 60 | MP0000358_abnormal_cell_content/ | 1.30519793 |
| 61 | * MP0002398_abnormal_bone_marrow | 1.27568762 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.26645740 |
| 63 | MP0002419_abnormal_innate_immunity | 1.25516252 |
| 64 | MP0000858_altered_metastatic_potential | 1.24942504 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.24264897 |
| 66 | MP0005365_abnormal_bile_salt | 1.23128971 |
| 67 | MP0006082_CNS_inflammation | 1.21878830 |
| 68 | MP0008995_early_reproductive_senescence | 1.21146429 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.20621487 |
| 70 | * MP0000716_abnormal_immune_system | 1.19483300 |
| 71 | MP0008789_abnormal_olfactory_epithelium | 1.18634175 |
| 72 | MP0002722_abnormal_immune_system | 1.18266257 |
| 73 | MP0003763_abnormal_thymus_physiology | 1.17928969 |
| 74 | MP0008058_abnormal_DNA_repair | 1.17555418 |
| 75 | MP0010234_abnormal_vibrissa_follicle | 1.17419650 |
| 76 | MP0005083_abnormal_biliary_tract | 1.17065035 |
| 77 | MP0008872_abnormal_physiological_respon | 1.16750602 |
| 78 | MP0008260_abnormal_autophagy | 1.15910830 |
| 79 | MP0003646_muscle_fatigue | 1.15865509 |
| 80 | MP0003724_increased_susceptibility_to | 1.14060329 |
| 81 | * MP0002429_abnormal_blood_cell | 1.13148887 |
| 82 | MP0005451_abnormal_body_composition | 1.12968297 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 1.12798860 |
| 84 | MP0008469_abnormal_protein_level | 1.11654558 |
| 85 | MP0009840_abnormal_foam_cell | 1.10926283 |
| 86 | MP0000516_abnormal_urinary_system | 1.10687524 |
| 87 | MP0005367_renal/urinary_system_phenotyp | 1.10687524 |
| 88 | MP0004947_skin_inflammation | 1.10553998 |
| 89 | MP0002019_abnormal_tumor_incidence | 1.09556881 |
| 90 | MP0008932_abnormal_embryonic_tissue | 1.09528949 |
| 91 | MP0005397_hematopoietic_system_phenotyp | 1.09063944 |
| 92 | MP0001545_abnormal_hematopoietic_system | 1.09063944 |
| 93 | MP0001845_abnormal_inflammatory_respons | 1.08831896 |
| 94 | MP0003191_abnormal_cellular_cholesterol | 1.07571617 |
| 95 | MP0003718_maternal_effect | 1.06507745 |
| 96 | MP0002405_respiratory_system_inflammati | 1.05878583 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 1.05555668 |
| 98 | MP0003567_abnormal_fetal_cardiomyocyte | 1.03442764 |
| 99 | MP0006054_spinal_hemorrhage | 1.03109643 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 1.00743888 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 0.99655182 |
| 102 | MP0009053_abnormal_anal_canal | 0.98677271 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 0.97024531 |
| 104 | MP0000343_altered_response_to | 0.96792310 |
| 105 | MP0001666_abnormal_nutrient_absorption | 0.96522113 |
| 106 | MP0009763_increased_sensitivity_to | 0.94953565 |
| 107 | MP0003448_altered_tumor_morphology | 0.93634261 |
| 108 | MP0001730_embryonic_growth_arrest | 0.93299248 |
| 109 | MP0000350_abnormal_cell_proliferation | 0.92981777 |
| 110 | MP0009764_decreased_sensitivity_to | 0.92098819 |
| 111 | MP0000383_abnormal_hair_follicle | 0.91726996 |
| 112 | MP0005408_hypopigmentation | 0.91574179 |
| 113 | MP0005379_endocrine/exocrine_gland_phen | 0.90434918 |
| 114 | MP0008877_abnormal_DNA_methylation | 0.90032467 |
| 115 | MP0003122_maternal_imprinting | 0.89562047 |
| 116 | MP0005332_abnormal_amino_acid | 0.89466101 |
| 117 | MP0003011_delayed_dark_adaptation | 0.89156175 |
| 118 | MP0001529_abnormal_vocalization | 0.87515994 |
| 119 | MP0003315_abnormal_perineum_morphology | 0.87435016 |
| 120 | MP0001764_abnormal_homeostasis | 0.87365735 |
| 121 | MP0002210_abnormal_sex_determination | 0.87092747 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.86549634 |
| 123 | MP0006036_abnormal_mitochondrial_physio | 0.86325316 |
| 124 | MP0003453_abnormal_keratinocyte_physiol | 0.86160909 |
| 125 | MP0001324_abnormal_eye_pigmentation | 0.85827585 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.85740465 |
| 127 | MP0005023_abnormal_wound_healing | 0.85677357 |
| 128 | MP0004264_abnormal_extraembryonic_tissu | 0.85015768 |
| 129 | MP0000598_abnormal_liver_morphology | 0.83094576 |
| 130 | MP0000681_abnormal_thyroid_gland | 0.82504858 |
| 131 | MP0008004_abnormal_stomach_pH | 0.82121132 |
| 132 | MP0000609_abnormal_liver_physiology | 0.82043788 |
| 133 | MP0001929_abnormal_gametogenesis | 0.81564081 |
| 134 | MP0004019_abnormal_vitamin_homeostasis | 0.80546730 |
| 135 | MP0002796_impaired_skin_barrier | 0.80173538 |
| 136 | MP0003866_abnormal_defecation | 0.79830702 |
| 137 | MP0002693_abnormal_pancreas_physiology | 0.78954226 |
| 138 | MP0002928_abnormal_bile_duct | 0.78782275 |
| 139 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78743217 |
| 140 | MP0010307_abnormal_tumor_latency | 0.78572574 |
| 141 | MP0002160_abnormal_reproductive_system | 0.77503913 |
| 142 | MP0003252_abnormal_bile_duct | 0.77006894 |
| 143 | MP0009697_abnormal_copulation | 0.76948074 |
| 144 | MP0004808_abnormal_hematopoietic_stem | 0.76255837 |
| 145 | * MP0000703_abnormal_thymus_morphology | 0.75525290 |
| 146 | MP0001293_anophthalmia | 0.74862515 |
| 147 | MP0001873_stomach_inflammation | 0.74685836 |
| 148 | MP0002876_abnormal_thyroid_physiology | 0.74160139 |
| 149 | MP0001663_abnormal_digestive_system | 0.73859097 |
| 150 | MP0001145_abnormal_male_reproductive | 0.72083987 |
| 151 | MP0001756_abnormal_urination | 0.71931901 |
| 152 | MP0002653_abnormal_ependyma_morphology | 0.71762811 |
| 153 | MP0005266_abnormal_metabolism | 0.69362033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.40276402 |
| 2 | Reticulocytopenia (HP:0001896) | 5.19956759 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 4.93614583 |
| 4 | Macrocytic anemia (HP:0001972) | 4.06562284 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.78807358 |
| 6 | Pallor (HP:0000980) | 3.49584228 |
| 7 | Progressive macrocephaly (HP:0004481) | 3.40643875 |
| 8 | Abnormal hemoglobin (HP:0011902) | 3.39197028 |
| 9 | Increased intramyocellular lipid droplets (HP:0012240) | 3.37514421 |
| 10 | Renal Fanconi syndrome (HP:0001994) | 3.35829487 |
| 11 | Multiple enchondromatosis (HP:0005701) | 3.35616840 |
| 12 | Thrombocytosis (HP:0001894) | 3.24850837 |
| 13 | Respiratory difficulties (HP:0002880) | 3.20547381 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.97705976 |
| 15 | Increased muscle lipid content (HP:0009058) | 2.93143794 |
| 16 | Lactic acidosis (HP:0003128) | 2.90899124 |
| 17 | Nemaline bodies (HP:0003798) | 2.90216135 |
| 18 | Aplastic anemia (HP:0001915) | 2.83025809 |
| 19 | Rhabdomyolysis (HP:0003201) | 2.63051350 |
| 20 | Muscle fiber inclusion bodies (HP:0100299) | 2.62278325 |
| 21 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.57559010 |
| 22 | Oral leukoplakia (HP:0002745) | 2.57325916 |
| 23 | Abnormality of renal resorption (HP:0011038) | 2.47117662 |
| 24 | Exercise intolerance (HP:0003546) | 2.40909315 |
| 25 | Respiratory failure (HP:0002878) | 2.40662470 |
| 26 | Papillary thyroid carcinoma (HP:0002895) | 2.34457386 |
| 27 | Hypobetalipoproteinemia (HP:0003563) | 2.31921150 |
| 28 | Delayed CNS myelination (HP:0002188) | 2.31707294 |
| 29 | Hepatic necrosis (HP:0002605) | 2.28625927 |
| 30 | Degeneration of anterior horn cells (HP:0002398) | 2.28502949 |
| 31 | Abnormality of the anterior horn cell (HP:0006802) | 2.28502949 |
| 32 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.28299096 |
| 33 | Intrahepatic cholestasis (HP:0001406) | 2.27232628 |
| 34 | IgM deficiency (HP:0002850) | 2.25682848 |
| 35 | Pustule (HP:0200039) | 2.25488974 |
| 36 | Methylmalonic aciduria (HP:0012120) | 2.24110224 |
| 37 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.23737569 |
| 38 | Villous atrophy (HP:0011473) | 2.23737569 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.21078333 |
| 40 | Chronic otitis media (HP:0000389) | 2.20927312 |
| 41 | Petechiae (HP:0000967) | 2.19769621 |
| 42 | Abnormality of reticulocytes (HP:0004312) | 2.19419398 |
| 43 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19025046 |
| 44 | Rimmed vacuoles (HP:0003805) | 2.19017422 |
| 45 | Generalized aminoaciduria (HP:0002909) | 2.17436127 |
| 46 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.17329901 |
| 47 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.17188572 |
| 48 | Colon cancer (HP:0003003) | 2.16958778 |
| 49 | Lipid accumulation in hepatocytes (HP:0006561) | 2.16356174 |
| 50 | Nausea (HP:0002018) | 2.15302281 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.14351121 |
| 52 | Abnormal hair whorl (HP:0010721) | 2.13693742 |
| 53 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.12798010 |
| 54 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.12163864 |
| 55 | Abnormality of glycolysis (HP:0004366) | 2.10157498 |
| 56 | Increased serum pyruvate (HP:0003542) | 2.10157498 |
| 57 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.09157808 |
| 58 | Recurrent bacterial skin infections (HP:0005406) | 2.09057982 |
| 59 | Congenital, generalized hypertrichosis (HP:0004540) | 2.08812036 |
| 60 | Increased hepatocellular lipid droplets (HP:0006565) | 2.07274743 |
| 61 | Myoglobinuria (HP:0002913) | 2.06625164 |
| 62 | Abnormal cartilage morphology (HP:0002763) | 2.06054322 |
| 63 | CNS demyelination (HP:0007305) | 2.04682063 |
| 64 | Recurrent abscess formation (HP:0002722) | 2.02516096 |
| 65 | Methylmalonic acidemia (HP:0002912) | 2.02007922 |
| 66 | Optic disc pallor (HP:0000543) | 2.00935215 |
| 67 | Palpitations (HP:0001962) | 1.99704400 |
| 68 | Spastic paraparesis (HP:0002313) | 1.99224280 |
| 69 | Hyperammonemia (HP:0001987) | 1.98696560 |
| 70 | X-linked dominant inheritance (HP:0001423) | 1.96687146 |
| 71 | Myositis (HP:0100614) | 1.96428211 |
| 72 | Recurrent viral infections (HP:0004429) | 1.95965027 |
| 73 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.95504619 |
| 74 | Birth length less than 3rd percentile (HP:0003561) | 1.94454962 |
| 75 | Trismus (HP:0000211) | 1.93744111 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.93668025 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 1.93668025 |
| 78 | 3-Methylglutaconic aciduria (HP:0003535) | 1.93357884 |
| 79 | Abnormality of methionine metabolism (HP:0010901) | 1.93303423 |
| 80 | Hypoglycemic coma (HP:0001325) | 1.93266498 |
| 81 | Hepatocellular necrosis (HP:0001404) | 1.92936501 |
| 82 | Amaurosis fugax (HP:0100576) | 1.92556611 |
| 83 | Hyperphosphaturia (HP:0003109) | 1.91738551 |
| 84 | Posterior subcapsular cataract (HP:0007787) | 1.91601149 |
| 85 | Granulocytopenia (HP:0001913) | 1.91555528 |
| 86 | Distal arthrogryposis (HP:0005684) | 1.91354137 |
| 87 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.91271922 |
| 88 | Gastrointestinal infarctions (HP:0005244) | 1.91005870 |
| 89 | Sparse eyelashes (HP:0000653) | 1.90771595 |
| 90 | Eosinophilia (HP:0001880) | 1.88757722 |
| 91 | Combined immunodeficiency (HP:0005387) | 1.88164192 |
| 92 | Stenosis of the external auditory canal (HP:0000402) | 1.88084288 |
| 93 | Microvesicular hepatic steatosis (HP:0001414) | 1.87641824 |
| 94 | Breast hypoplasia (HP:0003187) | 1.86343617 |
| 95 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.86114243 |
| 96 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.86114243 |
| 97 | Emotional lability (HP:0000712) | 1.86095910 |
| 98 | IgG deficiency (HP:0004315) | 1.85578852 |
| 99 | Hyperglycinemia (HP:0002154) | 1.85538391 |
| 100 | Poor head control (HP:0002421) | 1.85311988 |
| 101 | Cerebral edema (HP:0002181) | 1.85304274 |
| 102 | Rough bone trabeculation (HP:0100670) | 1.84199610 |
| 103 | Recurrent fungal infections (HP:0002841) | 1.83725413 |
| 104 | Thyroid carcinoma (HP:0002890) | 1.82686209 |
| 105 | Reduced antithrombin III activity (HP:0001976) | 1.82217250 |
| 106 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.81494058 |
| 107 | Eczematoid dermatitis (HP:0000976) | 1.80980655 |
| 108 | Increased serum lactate (HP:0002151) | 1.80746694 |
| 109 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.80544677 |
| 110 | Prolonged neonatal jaundice (HP:0006579) | 1.80384746 |
| 111 | Increased CSF lactate (HP:0002490) | 1.80220377 |
| 112 | Purpura (HP:0000979) | 1.79128356 |
| 113 | IgA deficiency (HP:0002720) | 1.79093661 |
| 114 | Cleft eyelid (HP:0000625) | 1.78834335 |
| 115 | Abnormality of macrophages (HP:0004311) | 1.78696835 |
| 116 | Tubulointerstitial nephritis (HP:0001970) | 1.78270403 |
| 117 | Autoimmune hemolytic anemia (HP:0001890) | 1.77923020 |
| 118 | Lethargy (HP:0001254) | 1.77754882 |
| 119 | Basal ganglia calcification (HP:0002135) | 1.76956623 |
| 120 | Exertional dyspnea (HP:0002875) | 1.76777680 |
| 121 | Constricted visual fields (HP:0001133) | 1.75946081 |
| 122 | Acute encephalopathy (HP:0006846) | 1.75677845 |
| 123 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.75451310 |
| 124 | Hyperglycinuria (HP:0003108) | 1.75258338 |
| 125 | Spastic diplegia (HP:0001264) | 1.74358558 |
| 126 | Cerebral hypomyelination (HP:0006808) | 1.74290955 |
| 127 | Metaphyseal dysplasia (HP:0100255) | 1.73150021 |
| 128 | Mitochondrial inheritance (HP:0001427) | 1.72629386 |
| 129 | Neoplasm of the adrenal gland (HP:0100631) | 1.71873819 |
| 130 | Increased serum ferritin (HP:0003281) | 1.71074734 |
| 131 | Acute necrotizing encephalopathy (HP:0006965) | 1.70860392 |
| 132 | Microretrognathia (HP:0000308) | 1.70606393 |
| 133 | Testicular atrophy (HP:0000029) | 1.70272690 |
| 134 | Abnormality of glycine metabolism (HP:0010895) | 1.69849210 |
| 135 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.69849210 |
| 136 | Increased IgM level (HP:0003496) | 1.68337446 |
| 137 | Cerebral palsy (HP:0100021) | 1.68234727 |
| 138 | Type 2 muscle fiber atrophy (HP:0003554) | 1.68175735 |
| 139 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.67449009 |
| 140 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.67449009 |
| 141 | Type I transferrin isoform profile (HP:0003642) | 1.67383016 |
| 142 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.66790425 |
| 143 | Skin ulcer (HP:0200042) | 1.66589582 |
| 144 | Delusions (HP:0000746) | 1.66528906 |
| 145 | Hypoplasia of the thymus (HP:0000778) | 1.66108314 |
| 146 | Panhypogammaglobulinemia (HP:0003139) | 1.65957457 |
| 147 | Recurrent skin infections (HP:0001581) | 1.65815625 |
| 148 | Pancytopenia (HP:0001876) | 1.65067275 |
| 149 | Lymphoma (HP:0002665) | 1.64539781 |
| 150 | Gangrene (HP:0100758) | 1.63950709 |
| 151 | Prolonged bleeding time (HP:0003010) | 1.63939376 |
| 152 | Cheilitis (HP:0100825) | 1.63787178 |
| 153 | Glycosuria (HP:0003076) | 1.63649522 |
| 154 | Abnormality of urine glucose concentration (HP:0011016) | 1.63649522 |
| 155 | Urticaria (HP:0001025) | 1.63187176 |
| 156 | Osteolytic defects of the hand bones (HP:0009699) | 1.63022198 |
| 157 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.63022198 |
| 158 | Abnormality of serum amino acid levels (HP:0003112) | 1.62229082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 4.74317849 |
| 2 | NME2 | 3.95450638 |
| 3 | MAP3K12 | 3.43690569 |
| 4 | VRK2 | 3.24050808 |
| 5 | PIM2 | 2.52493633 |
| 6 | BUB1 | 2.44832147 |
| 7 | MST4 | 2.34018572 |
| 8 | EIF2AK1 | 2.31863658 |
| 9 | WEE1 | 2.29407515 |
| 10 | MAP4K1 | 2.20338483 |
| 11 | LRRK2 | 2.05600563 |
| 12 | PDK2 | 2.01759219 |
| 13 | RIPK4 | 1.95243651 |
| 14 | BRSK2 | 1.92023005 |
| 15 | FLT3 | 1.90755166 |
| 16 | RPS6KB2 | 1.87640482 |
| 17 | MAP3K14 | 1.85537530 |
| 18 | PBK | 1.85049648 |
| 19 | ERBB3 | 1.85032019 |
| 20 | OBSCN | 1.67339819 |
| 21 | STK10 | 1.62778451 |
| 22 | TYK2 | 1.61627115 |
| 23 | NME1 | 1.60057799 |
| 24 | IRAK4 | 1.55981250 |
| 25 | IKBKB | 1.53401889 |
| 26 | STK16 | 1.52751448 |
| 27 | EPHA2 | 1.49839547 |
| 28 | TBK1 | 1.49060456 |
| 29 | SIK3 | 1.47406556 |
| 30 | WNK3 | 1.46565870 |
| 31 | RPS6KA4 | 1.43386150 |
| 32 | TESK2 | 1.42644268 |
| 33 | BMPR2 | 1.42224941 |
| 34 | ZAP70 | 1.33556701 |
| 35 | CDC7 | 1.32771875 |
| 36 | KIT | 1.31798450 |
| 37 | TRIM28 | 1.30422440 |
| 38 | VRK1 | 1.27381179 |
| 39 | DYRK3 | 1.25593055 |
| 40 | PIM1 | 1.24894609 |
| 41 | NEK9 | 1.24807925 |
| 42 | AURKB | 1.23689112 |
| 43 | BCKDK | 1.23283175 |
| 44 | SRPK1 | 1.23059731 |
| 45 | TXK | 1.22974510 |
| 46 | TTK | 1.21430620 |
| 47 | NEK2 | 1.20163856 |
| 48 | TGFBR1 | 1.18953328 |
| 49 | STK4 | 1.16711249 |
| 50 | PHKG2 | 1.15038863 |
| 51 | PHKG1 | 1.15038863 |
| 52 | JAK3 | 1.14876985 |
| 53 | TEC | 1.14491717 |
| 54 | TLK1 | 1.13837844 |
| 55 | PKN2 | 1.12763879 |
| 56 | CSF1R | 1.07485316 |
| 57 | CDK4 | 1.06746083 |
| 58 | IKBKE | 1.05745515 |
| 59 | CDK7 | 1.03568212 |
| 60 | DYRK2 | 1.03509639 |
| 61 | EIF2AK3 | 1.00701854 |
| 62 | MAP3K8 | 1.00257360 |
| 63 | PINK1 | 0.99666652 |
| 64 | IRAK3 | 0.96273593 |
| 65 | DAPK3 | 0.96056686 |
| 66 | PLK4 | 0.94374578 |
| 67 | PASK | 0.94182465 |
| 68 | ACVR1B | 0.93798233 |
| 69 | CHUK | 0.92393834 |
| 70 | DAPK1 | 0.91458276 |
| 71 | ABL2 | 0.90447691 |
| 72 | BTK | 0.90249445 |
| 73 | CDK6 | 0.89682247 |
| 74 | CAMKK2 | 0.89474670 |
| 75 | NLK | 0.87543346 |
| 76 | PLK1 | 0.85866689 |
| 77 | MAP2K3 | 0.85089328 |
| 78 | TSSK6 | 0.84664546 |
| 79 | EIF2AK2 | 0.84378492 |
| 80 | BCR | 0.82055768 |
| 81 | BMPR1B | 0.80703322 |
| 82 | BLK | 0.80257892 |
| 83 | FGFR4 | 0.79181250 |
| 84 | TAOK3 | 0.78720230 |
| 85 | MKNK1 | 0.77397312 |
| 86 | KDR | 0.76599359 |
| 87 | ATR | 0.74922690 |
| 88 | TGFBR2 | 0.73674386 |
| 89 | ERN1 | 0.71020350 |
| 90 | EEF2K | 0.70299812 |
| 91 | NEK1 | 0.69052761 |
| 92 | CLK1 | 0.68971670 |
| 93 | LMTK2 | 0.68857853 |
| 94 | STK24 | 0.67768067 |
| 95 | BRAF | 0.66826444 |
| 96 | STK3 | 0.66055371 |
| 97 | MAP2K7 | 0.65741304 |
| 98 | MAP2K2 | 0.65701533 |
| 99 | RPS6KA5 | 0.65215947 |
| 100 | TESK1 | 0.64550081 |
| 101 | LYN | 0.64370152 |
| 102 | PIK3CA | 0.64202881 |
| 103 | ILK | 0.64110985 |
| 104 | ITK | 0.62962516 |
| 105 | GRK5 | 0.61786198 |
| 106 | MAP3K3 | 0.61457112 |
| 107 | FGR | 0.61448816 |
| 108 | MST1R | 0.61391727 |
| 109 | GRK6 | 0.61131413 |
| 110 | PLK3 | 0.60169157 |
| 111 | CSNK2A1 | 0.58847425 |
| 112 | MATK | 0.58801843 |
| 113 | OXSR1 | 0.57970421 |
| 114 | MAP3K11 | 0.57028122 |
| 115 | ZAK | 0.56651119 |
| 116 | CSNK2A2 | 0.55931095 |
| 117 | MAPKAPK2 | 0.54844418 |
| 118 | NUAK1 | 0.54591111 |
| 119 | PAK2 | 0.54287284 |
| 120 | KSR1 | 0.54110721 |
| 121 | TRPM7 | 0.53780842 |
| 122 | BRSK1 | 0.53245987 |
| 123 | LCK | 0.52535891 |
| 124 | ARAF | 0.52494370 |
| 125 | PRKCQ | 0.51849880 |
| 126 | CHEK2 | 0.51613340 |
| 127 | PIK3CG | 0.50922997 |
| 128 | SYK | 0.50454925 |
| 129 | MARK3 | 0.49668820 |
| 130 | MAP3K2 | 0.48432270 |
| 131 | MAPK11 | 0.47740448 |
| 132 | DYRK1B | 0.47685662 |
| 133 | JAK1 | 0.44582775 |
| 134 | PAK4 | 0.43510121 |
| 135 | MAP3K4 | 0.42948476 |
| 136 | PAK1 | 0.42680114 |
| 137 | PRKCD | 0.42235687 |
| 138 | MYLK | 0.41054322 |
| 139 | TNK2 | 0.39807242 |
| 140 | CDK8 | 0.39454850 |
| 141 | HCK | 0.39331459 |
| 142 | MAPKAPK3 | 0.36008578 |
| 143 | TAF1 | 0.34499845 |
| 144 | CSK | 0.32481572 |
| 145 | CSNK1G2 | 0.31648714 |
| 146 | CSNK1G3 | 0.30797777 |
| 147 | FES | 0.29238589 |
| 148 | STK39 | 0.28103962 |
| 149 | MAP2K1 | 0.27238523 |
| 150 | RPS6KB1 | 0.25663072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.77665766 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.76796140 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.64626267 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 2.33606373 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.26881700 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.19979905 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.02187324 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99528945 |
| 9 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.95768869 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 1.80466826 |
| 11 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.77743503 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 1.75365781 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.74992092 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 1.73453421 |
| 15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.69967839 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.60925436 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45746577 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.45572001 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.41145452 |
| 20 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.38789819 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.38115796 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.34138395 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.33382970 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.33063921 |
| 25 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.32184777 |
| 26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.30894338 |
| 27 | RNA transport_Homo sapiens_hsa03013 | 1.29264117 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.20801693 |
| 29 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.15146814 |
| 30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.14257260 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.12996679 |
| 32 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.12139505 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.10071651 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.08102014 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.07587325 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06464670 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.05289067 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.04508279 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.04240648 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.02612581 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.02547429 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.02149148 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00656351 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99461851 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.99386146 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99311823 |
| 47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99301188 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98864275 |
| 49 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.98011620 |
| 50 | Parkinsons disease_Homo sapiens_hsa05012 | 0.97582135 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97472939 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96198328 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95366736 |
| 54 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92723790 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92628248 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92345034 |
| 57 | Peroxisome_Homo sapiens_hsa04146 | 0.91905702 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91695817 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.91234789 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.90005337 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89370402 |
| 62 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.89304249 |
| 63 | Cell cycle_Homo sapiens_hsa04110 | 0.87654036 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87560659 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87008856 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.86554334 |
| 67 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86097345 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85616069 |
| 69 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84615363 |
| 70 | Measles_Homo sapiens_hsa05162 | 0.84505913 |
| 71 | RNA degradation_Homo sapiens_hsa03018 | 0.83126947 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82636981 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79188220 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.78681986 |
| 75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78174307 |
| 76 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.77927459 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.77728009 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77434453 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73130556 |
| 80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72368507 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70646782 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70359325 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69824328 |
| 84 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.69606222 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68817027 |
| 86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68741907 |
| 87 | Basal transcription factors_Homo sapiens_hsa03022 | 0.68280174 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65376280 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65216826 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65200180 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65158905 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64967165 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.63368721 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.62806072 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61532693 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61037950 |
| 97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60758848 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60731371 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59995454 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59678690 |
| 101 | Asthma_Homo sapiens_hsa05310 | 0.58879038 |
| 102 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57331977 |
| 103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56982361 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56147497 |
| 105 | Apoptosis_Homo sapiens_hsa04210 | 0.54881645 |
| 106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54730894 |
| 107 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54185117 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53471295 |
| 109 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53169203 |
| 110 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52945772 |
| 111 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51896136 |
| 112 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49774243 |
| 113 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49312132 |
| 114 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49041746 |
| 115 | Influenza A_Homo sapiens_hsa05164 | 0.49006883 |
| 116 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47518670 |
| 117 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47371423 |
| 118 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47042823 |
| 119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.46686304 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.46383118 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43362240 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42281595 |
| 123 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39329795 |
| 124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34270675 |
| 125 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.27668996 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25507240 |
| 127 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23152207 |
| 128 | Tuberculosis_Homo sapiens_hsa05152 | 0.22387443 |
| 129 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.22064588 |
| 130 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21063321 |

